HMGB1 is considered a biomarker for ovarian cancer [38, 39] and increased levels of interleukin-8 protein (IL-8) and HMGB1 correlate with poor prognosis in prostate and ovarian cancer cells [125]. Here, CXCL8 is linked to ovarian cancer.